NGEN logo

NGENNervGen Pharma Corp

$1.86
$0.15
(7.46%)
Today
Closed $1.86
$0.0198
(1.06%)
After Hours
Updated: 07:53 PM EDT
Reported EarningsMay 15
Mkt Cap$150.53M
Vol1.06M

About

NervGen Pharma Corp. operates as a clinical stage biotech company. It engages in the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury and other neurotraumatic and neurologic conditions. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8

Frequently Asked Questions

What is Market Cap of NervGen Pharma Corp?
What is the 52-week high for NervGen Pharma Corp?
What is the 52-week low for NervGen Pharma Corp?
What is NervGen Pharma Corp stock price today?
What was NervGen Pharma Corp stock price yesterday?
What is the PE ratio of NervGen Pharma Corp?
What is the Price-to-Book ratio of NervGen Pharma Corp?
What is the 50-day moving average of NervGen Pharma Corp?
How many employees does NervGen Pharma Corp have?

Advertisement|Remove ads.